Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 5, 2014, Pages 151-157

  Taha, Ameer Y ^a   Cheon, Yewon ^a   Faurot, Keturah F ^c   MacIntosh, Beth ^d   Majchrzak Hong, Sharon F ^b   Mann, J Douglas ^c   Hibbeln, Joseph R ^b   Ringel, Amit ^b   Ramsden, Christopher E ^b,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

Arachidonic acid (AA); Chronic headache; Fish; Linoleic acid (LA) lowering; Omega 3 and omega 6 polyunsaturated fatty acids (PUFAs); Plasma fatty acid concentrations

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; DOCOSATETRAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FATTY ACID;

ADULT; ARTICLE; BIOAVAILABILITY; CHRONIC HEADACHE; COMPARATIVE STUDY; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; LIPID DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; ANIMAL; BLOOD; CHRONIC PAIN; DIET SUPPLEMENTATION; DIET THERAPY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RAT; TIME;

RATTUS;

ADULT; ANIMALS; CHRONIC PAIN; DIETARY SUPPLEMENTS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; RATS; TIME FACTORS;

EID: 84897577707     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.02.003     Document Type: Article

References (50)

1. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93:950-962.
2. Bazinet R.P., Douglas H., Cunnane S.C. Whole-body utilization of n-3 PUFA in n-6 PUFA-deficient rats. Lipids 2003, 38:187-189.
3. Domenichiello A.F., Chen C.T., Trepanier M.O., Stavro P.M., Bazinet R.P. Whole body synthesis rates of DHA from alpha-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats. J. Lipid Res. 2014, 55:62-74.
4. Carter J.R., Schwartz C.E., Yang H., Joyner M.J. Fish oil and neurovascular reactivity to mental stress in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013.
5. Dalli J., Colas R.A., Serhan C.N. Novel n-3 immunoresolvents: structures and actions. Sci. Rep. 2013, 3:1940.
6. Yurko-Mauro K., McCarthy D., Rom D., et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010, 6:456-464.
7. Ramsden C.E., Ringel A., Feldstein A.E., et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot. Essent. Fatty Acids 2012, 87:135-141.
8. Toborek M., Malecki A., Garrido R., Mattson M.P., Hennig B., Young.B. Arachidonic acid-induced oxidative injury to cultured spinal cord neurons. J. Neurochem. 1999, 73:684-692.
9. Feldstein A.E., Lopez R., Tamimi T.A., et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 2010, 51:3046-3054.
10. Mabalirajan U., Rehman R., Ahmad T., et al. Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Sci. Rep. 2013, 3:1349.
11. Yoshida Y., Yoshikawa A., Kinumi T., et al. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer[U+05F3]s disease patients and their potential as biomarkers. Neurobiol. Aging 2009, 30:174-185.
12. Bazan N.G. The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:127-129.
13. Orr S.K., Palumbo S., Bosetti F., et al. Unesterified docosahexaenoic acid is protective in neuroinflammation. J. Neurochem. 2013, 127:378-393.
14. Tjonahen E., Oh S.F., Siegelman J., et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol. 2006, 13:1193-1202.
15. Alvheim A.R., Malde M.K., Osei-Hyiaman D., et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 2012, 20:1984-1994.
16. Igarashi M., Gao F., Kim H.W., Ma K., Bell J.M., Rapoport S.I. Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim. Biophys. Acta 2009, 1791:132-139.
17. Igarashi M., Kim H.W., Chang L., Ma K., Rapoport S.I. Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain. J. Neurochem. 2012, 120:985-997.
18. Liou Y.A., King D.J., Zibrik D., Innis S.M. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J. Nutr. 2007, 137:945-952.
19. Macintosh B.A., Ramsden C.E., Faurot K.R., et al. Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research. Br. J. Nutr. 2013, 110:559-568.
20. Rett B.S., Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr. Metab. 2011, 8:36.
21. Hussein N., Ah-Sing E., Wilkinson P., Leach C., Griffin B.A., Millward D.J. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J. Lipid Res. 2005, 46:269-280.
22. Taha A.Y., Cheon Y., Ma K., Rapoport S.I., Rao J.S. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J. Psychiatr. Res. 2013, 47:636-643.
23. Taha A.Y., McIntyre Burnham W. Commentary on the effects of a ketogenic diet enriched with omega-3 polyunsaturated fatty acids on plasma phospholipid fatty acid profile in children with drug-resistant epilepsy. Epilepsy Res. 2007, 76:148-149. (discussion 150-141).
24. Ramsden C.E., Faurot K.R., Zamora D., et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain 2013, 154:2441-2451.
25. LaMancusa R., Pulcinelli F.M., Ferroni P., et al. Blood leukotrienes in headache: correlation with platelet activity. Headache 1991, 31:409-414.
26. Tuca J.O., Planas J.M., Parellada P.P. Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache 1989, 29:498-501.
27. Ramsden C.E., Mann J.D., Faurot K.R., et al. Low omega-6 vs. low omega-6 plus high omega-3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials 2011, 12:97.
28. Skipski V.P., Good J.J., Barclay M., Reggio R.B. Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta 1968, 152:10-19.
29. DeMar J.C., Ma K., Bell J.M., Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 2004, 91:1125-1137.
30. Cheon Y., Park J.Y., Modi H.R., et al. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain. J. Neurochem. 2011, 119:364-376.
31. Sublette M.E., Bosetti F., DeMar J.C., et al. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord. 2007, 9:759-765.
32. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47:348-380.
33. Lands W.E. Biosynthesis of prostaglandins. Annu. Rev. Nutr. 1991, 11:41-60.
34. Clark K.J., Makrides M., Neumann M.A., Gibson R.A. Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J. Pediatr. 1992, 120:S151-S158.
35. Tu W.C., Cook-Johnson R.J., James M.J., Muhlhausler B.S., Gibson.R.A. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot. Essent. Fatty Acids 2010, 83:61-68.
36. Guesnet P., Lallemand S.M., Alessandri J.M., Jouin M., Cunnane S.C. alpha-Linolenate reduces the dietary requirement for linoleate in the growing rat. Prostaglandins Leukot. Essent. Fatty Acids. 2011, 85:353-360.
37. Friesen R.W., Innis S.M. Linoleic acid is associated with lower long-chain n-6 and n-3 fatty acids in red blood cell lipids of Canadian pregnant women. Am. J. Clin. Nutr. 2010, 91:23-31.
38. Gavino V.C., Gavino G.R. Adipose hormone-sensitive lipase preferentially releases polyunsaturated fatty acids from triglycerides. Lipids 1992, 27:950-954.
39. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 1997, 38:2012-2022.
40. Gibson R.A., Neumann M.A., Lien E.L., Boyd K.A., Tu W.C. Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:139-146.
41. Pawlosky R.J., Hibbeln J.R., Lin Y., et al. Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am. J. Clin. Nutr. 2003, 77:565-572.
42. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:85-91.
43. Dodin S., Cunnane S.C., Masse B., et al. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 2008, 24:23-30.
44. Cazeils J.L., Bouillier-Oudot M., Auvergne A., Candau M., Babile R. Lipid composition of hepatocyte plasma membranes from geese overfed with corn. Lipids 1999, 34:937-942.
45. Chen C.T., Ma D.W., Kim J.H., Mount H.T., Bazinet.R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J. Lipid Res. 2008, 49:147-152.
46. Rahman T., Taha A.Y., Song B.J., et al. The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:141-145.
47. Garland M., Sacks F.M., Colditz G.A., et al. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am. J. Clin. Nutr. 1998, 67:25-30.
48. Kingsbury K.J., Heyes T.D., Morgan D.M., et al. The effect of dietary changes on the fatty acid composition of normal human depot fat. Biochem. J. 1962, 84:124-133.
49. Kingsbury K.J., Paul S., Crossley A., Morgan D.M. The fatty acid composition of human depot fat. Biochem. J. 1961, 78:541-550.
50. Kim H.W., Rao J.S., Rapoport S.I., Igarashi M. Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. Biochim. Biophys. Acta 2011, 1811:111-117.